HANNINEN, M.; VENNER, P.; NORTH, S. A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancer. Canadian Urological Association Journal, [S. l.], v. 3, n. 5, p. 369–74, 2013. DOI: 10.5489/cuaj.1145. Disponível em: https://cuaj.ca/index.php/journal/article/view/1145. Acesso em: 9 may. 2024.